شرکت سرمایه گذاری دارویی پورا دارو ایرانیان
  • تهران - خیابان خالداسلامبولی - خیابان هفتم پلاک 22

Entering the first biological drug produced by Puragen

Entering the first biological drug produced by Puragen in the market until 1404
The CEO of Pouragen Company announced the entry of the first biological drug produced by this company into the market in 1404 and said: This monoclonal antibody drug is currently in the stages of clinical testing, and after going through these stages and receiving the approval of the Food and Drug Organization, it will enter the market. 

She stated that Puragen Company currently has 12 products in the field of pharmaceutical supplies, including intra-articular injection gels, skin injection gels, and artificial tear eye drops, and the company's first product, i.e. intra-articular injection gels, entered the market in 1400, she said: Multi-dose eye drops and single dose are also in Puragen's pipeline and we predict that they will enter the market by 1403. Also, in September of this year, the new Puragen product, i.e. rejuvenation boosters, was produced and entered the market in three doses.
She pointed out: Currently, Puragen products are produced under contract and we plan to launch our independent line as well. In this regard, we are building a production line, which is expected to be put into operation by the end of 1403.

P.D.I Pharmaceutical Investment Co.

Active in the field of Pharmaceutical production and Blood Plasma products, Food and Sports supplements, Herbal medicines, Cosmetics and Hygiene, Food products, Medical and Laboratory equipment and Distribution